P20. The use of FDG and 124I PET in the localization and characterization of recurrent thyroid carcinoma

Julyan, P. J.; Fenton, J. L.; Hastings, D. L.; Bailey, J.; Zweit, Jamal; Carrington, Bernadette M; Hulse, Paul; Lawrance, Jeremy A L; Allan, Ernest

doi:10.1097/00006231-200204000-00100

Search citation statements

Order By: Relevance

Paper Sections

Select...

------------------------------------------------------------1

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2003

Publication Types

Select...

Article1

Relationship

Self Cite0

Independent1

Authors

Journals

Cited by 1 publication

(1 citation statement)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The benefits of [ 18 F]FDG have been recently combined with 124 I for evaluation of glucose and iodide metabolism in suspected recurrent thyroid carcinoma (174).…”

Section: ------------------------------------------------------------mentioning

confidence: 99%

Applications of positron-emitting halogens in PET oncology (Review)

Glaser

Luthra²,

Brady³

2003

Int J Oncol

View full text Add to dashboard Cite

The positron-emitting radiohalogens 18 F, 75 Br, 76 Br, and 124 I are reviewed regarding their relevance for positron emission tomography (PET) in oncology. Relevant production routes of these cyclotron-generated isotopes are given, followed by publications that deal with applications of these radiohalogens. This article tries to cover the whole literature for the non-conventional isotopes 75 Br, 76 Br, and 124 I. From the literature on 18 F, only articles since 2000 are considered. Here, the emphasis is also given to alternative biomarkers beyond [ 18 ]2-fluoro-2-deoxyglucose ([ 18 F]FDG). Contents 1. Introduction 2. Fluorine-18 3. Bromine-75 4. Bromine-76 5. Iodine-124 6. Conclusions

show abstract

“…The benefits of [ 18 F]FDG have been recently combined with 124 I for evaluation of glucose and iodide metabolism in suspected recurrent thyroid carcinoma (174).…”

Section: ------------------------------------------------------------mentioning

confidence: 99%